SCHEMBL21880385

SCHEMBL21880385

O=C(O)c1ccc2c(c1)NC(c1ccccc1)O2

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.50
▸ ALDH1A1 P00352 4/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ GAA P10253 4/20 0.44
▸ TDP1 Q9NUW8 1/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ PARP1 P09874 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.36
▸ POLB P06746 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ TTR P02766 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ KMO O15229 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21880766 0.88 ALDH1A1 (0.44) ALOX5ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23677051 0.79 ALOX5 (0.48) ALOX5MEN1KMT2AKDM4EGAA
SCHEMBL11560196 0.78 ALOX5 (0.44) ALOX5ALDH1A1MEN1KMT2AKDM4E
SCHEMBL22417632 0.76 GAA (0.46) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL541947 0.75 MEN1 (0.49) ALOX5ALDH1A1MEN1KMT2AKDM4E
SCHEMBL23677076 0.73 KDM4E (0.49) ALOX5ALDH1A1KDM4E
SCHEMBL23677047 0.73 ALOX5 (0.42) ALOX5MEN1KMT2AKDM4EPARP1
SCHEMBL23012794 0.73 HRH3 (0.38) ALDH1A1MEN1KMT2AKDM4EGAA
SCHEMBL23677019 0.72 ALOX5 (0.44) ALOX5MEN1KMT2AKDM4EHSD17B10
SCHEMBL11557968 0.72 ALOX5 (0.38) ALOX5ALDH1A1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11299484-B2 Inhibiting fatty acid synthase (FASN) FORMA THERAPEUTICS, INC. (US) 2022-04-12 — — US disclosed
US-20210024508-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FORMA THERAPEUTICS, INC. 2021-01-28 — — US disclosed
US-20200115368-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FORMA THERAPEUTICS, INC. 2020-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024508-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FASN, SCD, FADS1 ALOX5 56/4885ALDH1A1 1168/4885MEN1 4802/4885
US-20200115368-A1 INHIBITING FATTY ACID SYNTHASE (FASN) FASN, SCD, FADS1 ALOX5 56/4885ALDH1A1 1168/4885MEN1 4802/4885
US-11299484-B2 Inhibiting fatty acid synthase (FASN) FASN, SCD, FADS1 ALOX5 56/4885ALDH1A1 1168/4885MEN1 4802/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback